Identification of essential genes in the human fungal pathogen Aspergillus fumigatus by transposon mutagenesis

Eukaryotic Cell

Volumn 2, Issue 2, 2003, Pages 247-255

  Firon, Arnaud ^a   Villalba, François ^b   Beffa, Roland ^b   D'Enfert, Christophe ^a  

^a CNRS   (France)

^b BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; BASE SEQUENCE; CHROMOSOME MAPPING; DNA TRANSPOSABLE ELEMENTS; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; GENE TARGETING; GENOME, FUNGAL; HUMANS; MUTAGENESIS, INSERTIONAL; MUTATION; SEQUENCE HOMOLOGY, NUCLEIC ACID;

AEPYCEROS MELAMPUS; ASCOMYCOTA; ASPERGILLUS FUMIGATUS; FUNGI; FUSARIUM; FUSARIUM OXYSPORUM; SACCHAROMYCES CEREVISIAE;

EID: 0038058886     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.2.2.247-255.2003     Document Type: Article

References (54)

1. Akerley, B. J., E. J. Rubin, V. L. Novick, K. Amaya, N. Judson, and J. J. Mekalanos. 2002. A genome-scale analysis for identification of genes required for growth or survival of Haemophilus influenzae. Proc. Natl. Acad. Sci. USA 99:966-971.
2. Bowman, J. C., P. S. Hicks, M. B. Kurtz, H. Rosen, D. M. Schmatz, P. A. Liberator, and C. M. Douglas. 2002. The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro. Antimicrob. Agents Chemother. 46:3001-3012.
3. Brookman, J. L., and D. W. Denning. 2000. Molecular genetics in Aspergillus fumigatus. Curr. Opin. Microbiol. 3:468-474.
4. Brown, J. S., A. Aufauvre-Brown, and D. W. Holden. 1998. Insertional mutagenesis of Aspergillus fumigatus. Mol. Gen. Genet. 259:327-335.
5. Chun, K. T., H. J. Edenberg, M. R. Kelley, and M. G. Goebl. 1997. Rapid amplification of uncharacterized transposon-tagged DNA sequences from genomic DNA. Yeast 13:233-240.
6. Clutterbuck, A. J. 1992. Sexual and parasexual genetics of Aspergillus species. Bio/Technology 23:3-18.
7. Cove, D. J. 1976. Chlorate toxicity in Aspergillus nidulans. Studies of mutants altered in nitrate assimilation. Mol. Gen. Genet. 146:147-159.
8. Craig, N. L. 1997. Target site selection in transposition. Annu. Rev. Biochem. 66:437-474.
9. Daboussi, M. J. 1996. Fungal transposable elements: generators of diversity and genetic tools. J. Genet. 75:325-339.
10. De Backer, M. D., B. Nelissen, M. Logghe, J. Viaene, I. Loonen, S. Vandoninck, R. de Hoogt, S. Dewaele, F. A. Simons, P. Verhasselt, G. Vanhoof, R. Contreras, and W. H. Luyten. 2001. An antisense-based functional genomics approach for identification of genes critical for growth of Candida albicans. Nat. Biotechnol. 19:235-241.
11. d'Enfert, C. 1996. Selection of multiple disruption events in Aspergillus fumigatus using the orotidine-5′-decarboxylase gene, pyrG, as a unique transformation marker. Curr. Genet. 30:76-82.
12. d'Enfert, C., G. Weidner, P. C. Mol, and A. A. Brakhage. 1999. Transformation systems of Aspergillus fumigatus. New tools to investigate fungal virulence. Contrib. Microbiol. 2:149-166.
13. Denning, D. W. 1998. Invasive aspergillosis. Clin. Infect. Dis. 26:781-803.
14. Denning, D. W., M. J. Anderson, G. Turner, J. P. Latge, and J. W. Bennett. 2002. Sequencing the Aspergillus fumigatus genome. Lancet Infect. Dis. 2:251-253.
15. Ellis, M. 2002. Invasive fungal infections: evolving challenges for diagnosis and therapeutics. Mol. Immunol. 38:947-957.
16. Entrup, R., W. Langgut, T. Lisowsky, and E. Schweizer. 1992. A yeast nuclear mutation conferring temperature-sensitivity to the mitochondrial tryptophanyl-tRNA synthetase. Curr. Genet. 21:281-283.
17. Firon, A., A. Beauvais, J. P. Latgé, E. Couvé, M. C. Grosjean-Cournoyer, and C. d'Enfert. 2002. Characterization of essential genes by parasexual genetics in the human fungal pathogen Aspergillus fumigatus. Impact of genomic rearrangements associated with electroporation of DNA. Genetics 161:1077-1087.
18. Firon, A., and C. d'Enfert. 2002. Identifying essential genes in fungal pathogens of humans. Trends Microbiol. 10:456-462.
19. Georgopapadakou, N. H. 1998. Antifungals: mechanism of action and resistance, established and novel drugs. Curr. Opin. Microbiol. 1:547-557.
20. Giaever, G., A. M. Chu, L. Ni, C. Connelly, L. Riles, S. Veronneau, S. Dow, A. Lucau-Danila, K. Anderson, B. Andre, A. P. Arkin, A. Astromoff, M. El Bakkoury, R. Bangham, R. Benito, S. Brachat, S. Campanaro, M. Curtiss, K. Davis, A. Deutschbauer, K. D. Entian, P. Flaherty, F. Foury, D. J. Garfinkel, M. Gerstein, D. Gotte, U. Guldener, J. H. Hegemann, S. Hempel, Z. Herman, D. F. Jaramillo, D. E. Kelly, S. L. Kelly, P. Kotter, D. LaBonte, D. C. Lamb, N. Lan, H. Liang, H. Liao, L. Liu, C. Luo, M. Lussier, R. Mao, P. Menard, S. L. Ooi, J. L. Revuelta, C. J. Roberts, M. Rose, P. Ross-Macdonald, B. Scherens, G. Schimmack, B. Shafer, D. D. Shoemaker, S. Sookhai-Mahadeo, R. K. Storms, J. N. Strathern, G. Valle, M. Voet, G. Volckaert, C. Y. Wang, T. R. Ward, J. Wilhelmy, E. A. Winzeler, Y. Yang, G. Yen, E. Youngman, K. Yu, H. Bussey, J. D. Boeke, M. Snyder, P. Philippsen, R. W. Davis, and M. Johnston. 2002. Functional profiling of the Saccharomyces cerevisiae genome. Nature 418:387-391.
21. Groll, A. H., A. J. De Lucca, and T. J. Walsh. 1998. Emerging targets for the development of novel antifungal therapeutics. Trends Microbiol. 6:117-124.
22. Groll, A. H., S. C. Piscitelli, and T. J. Walsh. 1998. Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigntional compounds, and putative targets for antifungal drug development. Adv. Pharmacol. 44:343-500.
23. Groll, A. H., and T. J. Walsh. 2001. Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections. Expert Opin. Investig. Drugs 10:1545-1558.
24. Hamer, L., K. Adachi, M. V. Montenegro-Chamorro, M. M. Tanzer, S. K. Mahanty, C. Lo, R. W. Tarpey, A. R. Skalchunes, R. W. Heiniger, S. A. Frank, B. A. Darveaux, D. J. Lampe, T. M. Slater, L. Ramamurthy, T. M. DeZwaan, G. H. Nelson, J. R. Shuster, J. Woessner, and J. E. Hamer. 2001. Gene discovery and gene function assignment in filamentous fungi. Proc. Natl. Acad. Sci. USA 98:5110-5115.
25. Harris, S. D. 2001. Septum formation in Aspergillus nidulans. Curr. Opin. Microbiol. 4:736-739.
26. Haselbeck, R., D. Wall, B. Jiang, T. Ketela, J. Zyskind, H. Bussey, J. G. Foulkes, and T. Roemer. 2002. Comprehensive essential gene identification as a platform for novel anti-infective drug discovery. Curr. Pharm. Des. 8:1155-1172.
27. Hastie, A. C. 1970. Benlate-induced instability of Aspergillus diploids. Nature 226:771.
28. Hua-Van, A., J. A. Pamphile, T. Langin, and M. J. Daboussi. 2001. Transposition of autonomous and engineered impala transposons in Fusarium oxysporum and a related species. Mol. Gen. Genet. 264:724-731.
29. Jiang, B., H. Bussey, and T. Roemer. 2002. Novel strategies in antifungal lead discovery. Curr. Opin. Microbiol. 5:466-471.
30. Judson, N., and J. J. Mekalanos. 2000. Transposon-based approaches to identify essential bacterial genes. Trends Microbiol. 8:521-526.
31. Kumar, A., and M. Snyder. 2001. Emerging technologies in yeast genomics. Nat. Rev. Genet. 2:302-312.
32. Langin, T., P. Capy, and M. J. Daboussi. 1995. The transposable element impala, a fungal member of the Tc1-mariner superfamily. Mol. Gen. Genet. 246:19-28.
33. Latgé, J. P. 1999. Aspergillus fumigatus and aspergillosis. Clin. Microbiol. Rev. 12:310-350.
34. Latgé, J. P. 2001. The pathobiology of Aspergillus fumigatus. Trends Microbiol. 9:382-389.
35. Li Destri Nicosia, M. G., C. Brocard-Masson, S. Demais, A. Hua Van, M. J. Daboussi, and C. Scazzocchio. 2001. Heterologous transposition in Aspergillus nidulans. Mol. Microbiol. 39:1330-1344.
36. Lin, S., J. Schranz, and S. Teutsch. 2001. Aspergillosis case-fatality rate: systematic review of the literature. Clin. Infect. Dis. 32:358-366.
37. Lints, R., M. A. Davis, and M. J. Hynes. 1995. The positively acting amdA gene of Aspergillus nidulans encodes a protein with two C2H2 zinc-finger motifs. Mol. Microbiol. 15:965-975.
38. McNeil, M. M., S. L. Nash, R. A. Hajjeh, M. A. Phelan, L. A. Conn, B. D. Plikaytis, and D. W. Warnock. 2001. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin. Infect. Dis. 33:641-647.
39. McNew, J. A., J. G. Coe, M. Sogaard, B. V. Zemelman, C. Wimmer, W. Hong, and T. H. Sollner. 1998. Gos1p, a Saccharomyces cerevisiae SNARE protein involved in Golgi transport. FEBS Lett. 435:89-95.
40. Mirabito, P. M., and N. R. Morris. 1993. BIMA, a TPR-containing protein required for mitosis, localizes to the spindle pole body in Aspergillus nidulans. J. Cell Biol. 120:959-968.
41. Oakley, B. R., J. E. Rinehart, B. L. Mitchell, C. E. Oakley, C. Carmona, G. L. Gray, and G. S. May. 1987. Cloning, mapping and molecular analysis of the pyrG (orotidine-5′-phosphate decarboxylase) gene of Aspergillus nidulans. Gene 61:385-399.
42. Odds, F. C., N. A. Gow, and A. J. Brown. 2001. Fungal virulence studies come of age. Genome Biol. 2:1009.1-1009.4.
43. O'Donnell, K. L., A. H. Osmani, S. A. Osmani, and N. R. Morris. 1991. bimA encodes a member of the tetratricopeptide repeat family of proteins and is required for the completion of mitosis in Aspergillus nidulans. J. Cell Sci. 99:711-719.
44. Perfect, J. R. 1996. Fungal virulence genes as targets for antifungal chemotherapy. Antimicrob. Agents Chemother. 40:1577-1583.
45. Plasterk, R. H., Z. Izsvak, and Z. Ivics. 1999. Resident aliens: the Tc1/mariner superfamily of transposable elements. Trends Genet. 15:326-332.
46. Plyte, S. E., A. Feoktistova, J. D. Burke, J. R. Woodgett, and K. L. Gould. 1996. Schizosaccharomyces pombe skp1 + encodes a protein kinase related to mammalian glycogen synthase kinase 3 and complements a cdc14 cytokinesis mutant. Mol. Cell. Biol. 16:179-191.
47. Ross-Macdonald, P., P. S. Coelho, T. Roemer, S. Agarwal, A. Kumar, R. Jansen, K. H. Cheung, A. Sheehan, D. Symoniatis, L. Umansky, M. Heidtman, F. K. Nelson, H. Iwasaki, K. Hager, M. Gerstein, P. Miller, G. S. Roeder, and M. Snyder. 1999. Large-scale analysis of the yeast genome by transposon tagging and gene disruption. Nature 402:413-418.
48. Rubin, E. J., B. J. Akerley, V. N. Novik, D. J. Lampe, R. N. Husson, and J. J. Mekalanos. 1999. In vivo transposition of mariner-based elements in enteric bacteria and mycobacteria. Proc. Natl. Acad. Sci. USA 96:1645-1650.
49. Sanglard, D., and F. C. Odds. 2002. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2:73-85.
50. Timberlake, W. E. 1991. Cloning and analysis of fungal genes, p. 51-85. In J. W. Bennett and L. L. Lasure (ed.), More gene manipulations in fungi. Academic Press Inc., Oxford, England.
51. van Burik, J. A., and P. T. Magee. 2001. Aspects of fungal pathogenesis in humans. Annu. Rev. Microbiol. 55:743-772.
52. Villalba, F., M. H. Lebrun, A. Hua-Van, M. J. Daboussi, and M. C. Grosjean-Cournoyer. 2001. Transposon impala, a novel tool for gene tagging in the rice blast fungus Magnaporthe grisea. Mol. Plant-Microbe Interact. 14:308-315.
53. Walsh, T. J., and A. H. Groll. 1999. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transplant. Infect. Dis. 1:247-261.
54. Waring, R. B., and C. Scazzocchio. 1980. Nuclear and mitochondrial suppression of a mitochondrially inherited cold-sensitive mutation in Aspergillus nidulans. J. Gen. Microbiol. 119:297-311.